About Amaros
Amaros is a Healthcare company based in Menlo Park (United States) founded in 2017. AI-based services for ophthalmology clinical trials are provided. Amaros has raised $1.26 million across 1 funding round. Amaros offers products and services including Ophthalmic Evidence Engine, Image-Based Biomarker, and Highly Intuitive Analytics. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its legal entity is Amaros, Inc. Its competitors include Surface Ophthalmics, SpyGlass Ophthalmics and Trial Runners; 2 of its 3 listed competitors have raised funding.
Company details
Amaros was founded in 2017 and is located in Menlo Park, United States. AI technologies are utilized by the company to support clinical trials in ophthalmology. Operations involve data analysis and process optimization within the healthcare sector, specifically targeting eye-related medical research. Services are delivered through a digital platform accessible via amaros.ai, aiding trial efficiency for pharmaceutical and research entities.
- Total Equity Funding$1.26M (USD)
in 1 rounds
- Latest Funding Round$1.26M (USD), Seed
Mar 2025
Products & Services of Amaros
Amaros offers a comprehensive portfolio of products and services, including Ophthalmic Evidence Engine, Image-Based Biomarker, and Highly Intuitive Analytics.
AI tool for curating longitudinal patient data in ophthalmology.
Unlocks clinical data for disease-specific insights and monitoring.
Provides access to metrics for financial and operational efficiency.
Funding Insights of Amaros
Amaros has successfully raised a total of $1.26M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.26 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.26M
- Total Rounds 1
- Last Round Seed — $1.26M
- First Round $1.26M
(Mar 2025)
All 1 funding rounds of Amaros with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2025 | $1.26M | Seed | – | – | – |
People of Amaros
5 people are tracked at Amaros (4 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Chet Kumar | Head Of Life Sciences | Leadership |
Davit Shahnazaryan | Chief Technology Officer | Leadership |
Ben Toker | Co-founder / CTO | Leadership |
Vartan Ghazarossian | CEO | Leadership |
Davit Harutyunyan | Lead Software Engineer | Team |
Complete people profiles for Amaros
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Amaros
2 dated milestones of Amaros across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Amaros is founded.
- Funding First funding round of $1.3M.
Competitors of Amaros
Amaros has 3 listed competitors in our database, 2 of them funded. They include Surface Ophthalmics, SpyGlass Ophthalmics and Trial Runners.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| surfaceophthalmics.com | 2020 | United States | $25M | Clinical development and research services for ophthalmology are provided. | ||
| spyglassophthalmics.com | 2019 | Mission Viejo, United States | $33.53M | Drug research and development services for ophthalmic diseases are provided. | ||
| trialrunners.com | 2006 | Dickinson, United States | 57 | Specializes in ophthalmology clinical trials and contract research services. |
Detailed competitors of Amaros
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Amaros
The website of Amaros (amaros.ai) receives about 3.7K visits a month.
- Monthly visits3.7K
▲ 34.9% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Amaros (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Amaros
Amaros was founded in 2017 and raised its 1st funding round 8 years after it was founded.
Amaros is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Amaros is a funded company, having raised a total of $1.26M across 1 funding round to date. The company's 1st funding round was a Seed of $1.26M, raised on Mar 2025.
Amaros was founded in 2017 and is located in Menlo Park, United States. AI technologies are utilized by the company to support clinical trials in ophthalmology. Operations involve data analysis and process optimization within the healthcare sector, specifically targeting eye-related medical research. Services are delivered through a digital platform accessible via amaros.ai, aiding trial efficiency for pharmaceutical and research entities.
Amaros's top competitors include SpyGlass Ophthalmics, Surface Ophthalmics and Trial Runners.
Amaros offers Ophthalmic Evidence Engine, Image-Based Biomarker, and Highly Intuitive Analytics.
Amaros operates through Amaros, Inc..